A1,
A2,
B,
C1,
C2,
D,
E,
F,
G-H,
I-K,
L,
M,
N,
O,
P1,
P2,
Q-R,
S,
T,
U-V,
W-Z
Urso Indications, Dosage, Storage, Stability - Ursodiol
Urso Indications, Dosage, Storage, Stability - Ursodiol
INDICATIONS AND USAGE
URSO 250® and URSO ForteTM (ursodiol) tablets are indicated for the treatment of patients with primary biliary cirrhosis.
DOSAGE AND ADMINISTRATION
The recommended adult dosage for URSO 250® and URSO ForteTM in the treatment of PBC is 13-15 mg/kg/day administered in two to four divided doses with food. Dosing regimen should be adjusted according to each patient’s need at the discretion of the physician.
HOW SUPPLIED
Each URSO 250® elliptical, biconvex, film-coated tablet, white, engraved with "URS785", contains 250 mg of ursodiol. Available in bottles of 100 tablets (NDC 58914-785-10) and 500 tablets (NDC 58914-785-50).
Each URSO ForteTM elliptical, biconvex, film-coated tablet, white, engraved with "URS790", contains 500 mg of ursodiol. Available in bottles of 100 tablets (NDC 58914-790-10) and 500 tablets (NDC 58914-790-50).
Store at 20oC to 25oC (68oF to 77oF). Dispense in a tight container.
Manufactured in Canada for: AXCAN SCANDIPHARM INC., 22 Inverness Center Parkway, Birmingham, AL 35242, USA, July 2004, Printed in Canada.
AXCAN SCANDIPHARM INC., 22 Inverness Center Parkway Birmingham, Alabama 35242, Tel (800) 472-2634, Fax(205) 991-8426 www.axcan.com.
® Registered trademarks, TM trademarks, and SM servicemarks are used under license by Axcan Scandipharm Inc., Actigall® is a registered trademark of Watson Pharmaceuticals, Inc., ©2004 Axcan Scandipharm
top
